Fjarde AP Fonden Fourth Swedish National Pension Fund Decreases Position in Danaher Corporation (NYSE:DHR)

Key Points

• Fjarde AP Fonden Fourth Swedish National Pension Fund reduced its stake in Danaher Corporation by 14.1%, selling 14,500 shares during the first quarter.
• Danaher reported a 3.4% year-over-year increase in revenue, achieving $5.94 billion and surpassing analysts' expectations.
• Analyst ratings reflect a generally positive outlook, with 18 analysts giving Danaher a buy rating and an average price target of $247.61.

Fjarde AP Fonden Fourth Swedish National Pension Fund decreased its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 14.1% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 88,272 shares of the conglomerate's stock after selling 14,500 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in Danaher were worth $18,096,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Heck Capital Advisors LLC purchased a new stake in shares of Danaher during the 4th quarter valued at about $27,000. GHP Investment Advisors Inc. increased its position in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the last quarter. Sierra Ocean LLC increased its position in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in Danaher in the 1st quarter worth approximately $31,000. Finally, Dunhill Financial LLC increased its holdings in Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after acquiring an additional 67 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Price Performance

Shares of DHR stock opened at $209.28 on Thursday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90. The firm has a market capitalization of $149.85 billion, a price-to-earnings ratio of 44.53, a PEG ratio of 2.87 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The stock's 50-day simple moving average is $199.27 and its 200-day simple moving average is $200.40.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. Danaher's revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.72 earnings per share. As a group, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on DHR shares. Robert W. Baird increased their target price on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Royal Bank Of Canada reissued an "outperform" rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Barclays reissued an "overweight" rating and issued a $225.00 target price (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Finally, Leerink Partners increased their target price on shares of Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a report on Wednesday, April 23rd. Three equities research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company's stock. According to data from MarketBeat, Danaher has an average rating of "Moderate Buy" and an average price target of $247.61.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.